Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia
Bioengineering,
Год журнала:
2025,
Номер
12(1), С. 92 - 92
Опубликована: Янв. 20, 2025
Critical
limb
ischemia
(CLI)
poses
a
substantial
and
intricate
challenge
in
vascular
medicine,
necessitating
the
development
of
innovative
therapeutic
strategies
to
address
its
multifaceted
pathophysiology.
Conventional
revascularization
approaches
often
fail
adequately
complexity
CLI,
identification
alternative
methodologies.
This
review
explores
uncharted
territory
beyond
traditional
therapies,
focusing
on
potential
two
distinct
yet
interrelated
entities:
cell-derived
extracellular
vesicles
(EVs)
artificial
nanovesicles.
Cell-derived
EVs
are
small
membranous
structures
naturally
released
by
cells,
nanovesicles
artificially
engineered
nanosized
vesicles.
Both
these
represent
promising
avenues
for
intervention.
They
act
as
carriers
bioactive
cargo,
including
proteins,
nucleic
acids,
lipids,
that
can
modulate
cellular
responses
associated
with
ischemic
tissue
repair
angiogenesis.
also
assesses
evolving
landscape
CLI
through
unique
perspective
The
spans
spectrum
from
early
preclinical
investigations
latest
translational
advancements,
providing
comprehensive
overview
current
state
research
this
emerging
field.
These
groundbreaking
vesicle
therapies
hold
immense
revolutionizing
treatment
paradigms.
Язык: Английский
Expanding the role of exosomes in drug, biomolecule, and nanoparticle delivery
Life Sciences,
Год журнала:
2025,
Номер
368, С. 123499 - 123499
Опубликована: Фев. 22, 2025
Язык: Английский
Composition, functions, and applications of exosomal membrane proteins
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Авг. 1, 2024
Exosomes
play
a
crucial
role
in
various
biological
processes,
such
as
human
development,
immune
responses,
and
disease
occurrence.
The
membrane
proteins
on
exosomes
are
pivotal
factors
for
their
functionality.
Currently,
numerous
have
been
identified
exosome
membranes,
participating
intercellular
communication,
mediating
target
cell
recognition,
regulating
processes.
Furthermore,
from
derived
cancer
cells
can
serve
relevant
biomarkers
early
diagnosis.
This
article
provides
comprehensive
review
of
the
composition
diverse
functions
organism's
Through
in-depth
exploration
proteins,
it
is
expected
to
offer
essential
foundations
future
development
novel
biomedical
diagnostics
therapies.
Язык: Английский
Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment
Biomedicines,
Год журнала:
2024,
Номер
12(8), С. 1822 - 1822
Опубликована: Авг. 11, 2024
The
increase
in
the
variety
of
nano-based
tools
offers
new
possibilities
to
approach
therapy
poorly
treatable
tumors,
which
includes
glioblastoma
multiforme
(GBM;
a
primary
brain
tumor).
available
nanocomplexes
exhibit
great
potential
as
vehicles
for
targeted
delivery
anti-GBM
compounds,
including
chemotherapeutics,
nucleic
acids,
and
inhibitors.
main
advantages
nanoparticles
(NPs)
include
improved
drug
stability,
increased
penetration
blood-brain
barrier,
better
precision
tumor
targeting.
Importantly,
alongside
their
drug-delivery
ability,
NPs
may
also
present
theranostic
properties,
applications
imaging
or
photothermal
malignant
cells.
can
be
classified
into
two
categories
according
core,
metal
non-metal
based.
Among
NPs,
most
studied
regard
GBM
treatment
are
exosomes,
liposomes,
cubosomes,
polymeric
micelles,
dendrimers,
nanogels,
carbon
nanotubes,
silica-
selenium-based
NPs.
They
characterized
by
satisfactory
stability
biocompatibility,
limited
toxicity,
high
accumulation
tissue.
Moreover,
they
easily
functionalized
cargo
Therefore,
discussed
here,
offer
promising
improving
outcomes
aggressive
tumors.
Язык: Английский
State-of-the-art photodynamic therapy for malignant gliomas: innovations in photosensitizers and combined therapeutic approaches
Exploration of Targeted Anti-tumor Therapy,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 28, 2025
Glioblastoma
(GBM),
the
most
aggressive
and
lethal
primary
brain
tumor,
poses
a
significant
therapeutic
challenge
due
to
its
highly
invasive
nature
resistance
conventional
therapies,
including
surgery,
chemotherapy,
radiotherapy.
Despite
advances
in
standard
treatments,
patient
survival
remains
limited,
requiring
exploration
of
innovative
strategies.
Photodynamic
therapy
(PDT)
has
emerged
as
promising
approach,
leveraging
light-sensitive
photosensitizers
(PSs),
molecular
oxygen,
specific
light
wavelengths
generate
reactive
oxygen
species
(ROS)
that
selectively
induce
tumor
cell
death.
Originally
developed
for
skin
cancer,
PDT
evolved
target
more
complex
malignancies,
GBM.
The
refinement
second-
third-generation
PS,
coupled
with
advancements
nanotechnology,
significantly
improved
PDT's
selectivity,
bioavailability,
efficacy.
Moreover,
combination
targeted
therapy,
immunotherapy,
among
other
modalities,
shown
potential
enhancing
outcomes.
This
review
provides
comprehensive
analysis
preclinical
clinical
applications
GBM,
detailing
mechanisms
action,
evolution
novel
combinatory
strategies
optimize
treatment
However,
several
challenges
remain,
overcoming
GBM-associated
hypoxia,
PS
delivery
across
blood-brain
barrier,
mitigating
mechanisms.
integration
genetic
insight,
alongside
cutting-edge
nanotechnology-based
systems,
may
revolutionize
GBM
treatment,
offering
new
prospects
quality
life.
Язык: Английский
Cryo-Trojan Mesenchymal Stem Cells as Non-Living Tumor-Homing Supercarriers for Enhanced Drug Delivery and Immune Activation in Prostate Cancer
Materials Today Bio,
Год журнала:
2025,
Номер
32, С. 101650 - 101650
Опубликована: Март 12, 2025
Prostate
cancer
remains
a
leading
cause
of
cancer-related
mortality,
with
conventional
therapies
limited
by
systemic
toxicity
and
poor
tumor
targeting.
Developing
innovative
drug
delivery
systems
that
enhance
therapeutic
specificity
while
minimizing
off-target
effects
is
critical.
We
engineered
cryo-trojan
human
umbilical
cord
mesenchymal
stem
cells
(CT-MSCs)
as
non-living,
tumor-homing
carriers
for
mitoxantrone
(MTX),
termed
CT-MTX.
Cryo-treatment
preserved
structural
integrity
chemokine
receptors
(CXCR4/CCR2)
targeting
eliminating
proliferative
risks.
Comprehensive
evaluations
included
loading/release
kinetics,
in
vitro
suppression,
immunogenic
cell
death
(ICD)
induction,
vivo
efficacy/safety
prostate
models.
CT-MTX
demonstrated
superior
loading
(116.38
μg/106
cells)
pH-sensitive
release
(74.10
%
at
pH
5.5),
outperforming
exosomes,
liposomes,
living
MSCs
stability
tumor-specific
delivery.
Compared
to
liposomes
(low
targeting)
nanomaterials
(biocompatibility
concerns),
leveraged
MSC-derived
tropism
without
tumorigenic
In
vitro,
inhibited
proliferation
(84.83
MTX
uptake),
migration
(4.42
residual
migration),
induced
apoptosis
(43.23
late
apoptosis).
Mechanistically,
triggered
ICD
via
PAMPs
release,
activating
CD8+
T
suppressing
immunosuppressive
Treg.
vivo,
selectively
accumulated
tumors,
reducing
growth
87.88
extending
survival
(93.30
vs.
66.70
controls)
negligible
toxicity.
Proteomics
revealed
enriched
immune
pathways
like
NK
cytotoxicity,
validating
its
dual
role
direct
killing
activation.
represents
novel,
non-proliferative
platform
combines
the
capacity
enhanced
safety
controlled
inducing
ICDs
other
immunologically
"cold"
tumors
improve
infiltration.
Язык: Английский
Trends in nanomedicine for colorectal cancer treatment: Bibliometric and visualization analysis (2010-2024)
World Journal of Gastrointestinal Oncology,
Год журнала:
2025,
Номер
17(4)
Опубликована: Март 24, 2025
Recently,
numerous
studies
have
reported
the
application
of
nanomedicines
in
colorectal
cancer
treatment.
However,
no
systematic
bibliometric
analysis
has
been
conducted
to
examine
potential
and
mechanisms
action
nanomedicine
this
context.
Such
an
may
provide
a
comprehensive
overview
current
research
landscape,
identify
emerging
trends,
highlight
key
areas
for
future
investigation.
To
describe
global
landscape
on
The
Web
Science
Core
Collection
database
was
searched
literature
published
from
January
1,
2010,
August
7,
2024,
focusing
Bibliometric
visualization
mapping
countries,
institutions,
authors,
keywords,
references
relevant
were
using
CiteSpace
(6.2R6),
VOSviewer
(1.6.20),
bibliometrix
(based
R
4.3.2).
A
total
3598
articles
included,
with
rapid
increase
publication
volume
starting
2010.
China
most
papers
topic,
followed
by
United
States
India.
emerged
as
central
country
field,
Egyptian
Knowledge
Bank
Chinese
Academy
Sciences
institutions
highest
number
publications.
exhibited
centrality.
prolific
author
Zhang
Y,
whereas
Siegel
RL
cited
author,
Li
Y
had
H-index.
International
Journal
Nanomedicine
publications
Biomaterials
received
citations.
Keyword
co-occurrence
identified
11837
keywords
grouped
into
13
clusters
15
high-frequency
highlighted
keywords.
top
three
keyword
"0
cancer",
"1
drug
delivery",
"2
being
"nanoparticles",
"colorectal
"drug
delivery".
Research
surged
since
"nanoparticles"
Future
should
investigate
nanomaterial
stability
target-specific
release.
Язык: Английский
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy
Cancer Cell International,
Год журнала:
2024,
Номер
24(1)
Опубликована: Окт. 5, 2024
Язык: Английский
Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles as Natural Nanocarriers in the Treatment of Nephrotoxic Injury In Vitro
Cells,
Год журнала:
2024,
Номер
13(19), С. 1658 - 1658
Опубликована: Окт. 7, 2024
Umbilical
cord
mesenchymal
stem
cell-derived
extracellular
vesicles
(UC-EVs)
are
valuable
in
nanomedicine
as
natural
nanocarriers,
carrying
information
molecules
from
their
parent
cells
and
fusing
with
targeted
cells.
miRNA-126,
specific
to
endothelial
derived
these
vesicles,
supports
vascular
integrity
angiogenesis
has
protective
effects
kidney
diseases.
Язык: Английский